Publications searcher The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points. Fulltext search Alphabetic A-Z Alphabetic Z-A Myocardial Injury After Noncardiac Surgery. Could Dabigatran Be a First Step in Its Management? PMID: 31401086 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2019 Reference: Rev Esp Cardiol (Engl Ed). 2019 Oct;72(10):803-805. doi: 10.1016/j.rec.2019.03.018. Epub 2019 Aug 7. Impact factor: 5.078 Publication type: Editorial in national publication Authors: Alvarez-Garcia, Jesus, de Nadal, Miriam, Popova, Ekaterina et al. DOI: 10.1016/j.rec.2019.03.018 Myocardial Injury After Noncardiac Surgery. Could Dabigatran Be a First Step in Its Management? PMID: 31401086 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2019 Reference: Rev Esp Cardiol (Engl Ed). 2019 Oct;72(10):803-805. doi: 10.1016/j.rec.2019.03.018. Epub 2019 Aug 7. Impact factor: Publication type: Editorial in national publication Authors: Alvarez-Garcia, Jesus; de Nadal, Miriam; Popova, Ekaterina et al. DOI: 10.1016/j.rec.2019.03.018 MYO-MRI diagnostic protocols in genetic myopathies. PMID: 31727541 Journal: NEUROMUSCULAR DISORDERS Year: 2019 Reference: Neuromuscul Disord. 2019 Nov;29(11):827-841. doi: 10.1016/j.nmd.2019.08.011. Epub 2019 Sep 16. Impact factor: 2.612 Publication type: Review in international publication Authors: Chardon, Jodi Warman, Diaz-Manera, Jordi, Tasca, Giorgio, Bonnemann, Carsten G, Gomez-Andres, David, Heerschap, Arend, Mercuri, Eugenio, Muntoni, Francesco, Pichiecchio, Anna, Ricci, Enzo et al. DOI: 10.1016/j.nmd.2019.08.011 MYO-MRI diagnostic protocols in genetic myopathies. PMID: 31727541 Journal: NEUROMUSCULAR DISORDERS Year: 2019 Reference: Neuromuscul Disord. 2019 Nov;29(11):827-841. doi: 10.1016/j.nmd.2019.08.011. Epub 2019 Sep 16. Impact factor: Publication type: Review in international publication Authors: Bonnemann, Carsten G; Carlier, Robert Y; Chardon, Jodi Warman; Diaz-Manera, Jordi; Gomez-Andres, David; Hanna, Michael; Heerschap, Arend; Jungbluth, Heinz; Mercuri, Eugenio; Morrow, Jasper M et al. DOI: 10.1016/j.nmd.2019.08.011 Myositis autoantigen expression correlates with muscle regeneration but not autoantibody specificity. PMID: 30861336 Journal: Arthritis & Rheumatology Year: 2019 Reference: Arthritis Rheumatol. 2019 Aug;71(8):1371-1376. doi: 10.1002/art.40883. Epub 2019 Jun 18. Impact factor: 9.002 Publication type: Paper in international publication Authors: Pinal-Fernandez, Iago, Amici, David R, Parks, Cassie A, Derfoul, Assia, Casal-Dominguez, Maria, Pak, Katherine, Yeker, Richard, Plotz, Paul, Milisenda, Jose C, Selva-O'Callaghan, Albert et al. DOI: 10.1002/art.40883 Myositis autoantigen expression correlates with muscle regeneration but not autoantibody specificity. PMID: 30861336 Journal: Arthritis & Rheumatology Year: 2019 Reference: Arthritis Rheumatol. 2019 Aug;71(8):1371-1376. doi: 10.1002/art.40883. Epub 2019 Jun 18. Impact factor: Publication type: Paper in international publication Authors: Albayda, Jemima; Amici, David R; Casal-Dominguez, Maria; Christopher-Stine, Lisa; Corse, Andrea M; Derfoul, Assia; Grau-Junyent, Josep M; Lloyd, Thomas E; Mammen, Andrew L; Milisenda, Jose C et al. DOI: 10.1002/art.40883 Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study. PMID: 30442823 Journal: JOURNAL OF RHEUMATOLOGY Year: 2019 Reference: J Rheumatol. 2019 Mar;46(3):279-284. doi: 10.3899/jrheum.180355. Epub 2018 Nov 15. Impact factor: 3.634 Publication type: Paper in international publication Authors: Mosca, Marta, Bauhammer, Jutta, Miehle, Nikolaus, Parisi, Simone, Cavagna, Lorenzo, Codullo, Veronica, Montecucco, Carlomaurizio, Lopez-Longo, Francisco Javier, Martinez-Barrio, Julia, Nieto-Gonzalez, Juan Carlos et al. DOI: 10.3899/jrheum.180355 Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study. PMID: 30442823 Journal: JOURNAL OF RHEUMATOLOGY Year: 2019 Reference: J Rheumatol. 2019 Mar;46(3):279-284. doi: 10.3899/jrheum.180355. Epub 2018 Nov 15. Impact factor: Publication type: Paper in international publication Authors: Araguas, Ernesto Trallero; Barsotti, Simone; Bauhammer, Jutta; Bergner, Raoul; Bertolazzi, Chiara; Bonella, Francesco; Bortoluzzi, Alessandra; Caproni, Marzia; Cassone, Giulia; Castaneda, Santos et al. DOI: 10.3899/jrheum.180355 Nanoparticles as theranostic vehicles in prostate cancer. PMID: 31032309 Journal: Annals of Translational Medicine Year: 2019 Reference: Ann Transl Med. 2019 Mar;7(Suppl 1):S29. doi: 10.21037/atm.2019.01.77. Impact factor: 3.689 Publication type: Editorail in international publication Authors: Morales-Barrera, Rafael, Suarez, Cristina, Mateo, Joaquin, Gonzalez, Macarena, Carles, Joan et al. DOI: 10.21037/atm.2019.01.77 Nanoparticles as theranostic vehicles in prostate cancer. PMID: 31032309 Journal: Annals of Translational Medicine Year: 2019 Reference: Ann Transl Med. 2019 Mar;7(Suppl 1):S29. doi: 10.21037/atm.2019.01.77. Impact factor: Publication type: Editorail in international publication Authors: Carles, Joan; Gonzalez, Macarena; Mateo, Joaquin; Morales-Barrera, Rafael; Suarez, Cristina et al. DOI: 10.21037/atm.2019.01.77 Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. PMID: 31226355 Journal: JOURNAL OF CONTROLLED RELEASE Year: 2019 Reference: J Control Release. 2019 Aug 10;307:108-138. doi: 10.1016/j.jconrel.2019.06.017. Epub 2019 Jun 19. Impact factor: 7.901 Publication type: Paper in international publication Authors: Conniot, Joao, Fourniols, Thibaut, Scomparin, Anna, Martinez-Barriocanal, Agueda, Arango, Diego, Conde, Joao P, Preat, Veronique, Satchi-Fainaro, Ronit, Florindo, Helena F, Moura, Liane I F et al. DOI: 10.1016/j.jconrel.2019.06.017 Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. PMID: 31226355 Journal: JOURNAL OF CONTROLLED RELEASE Year: 2019 Reference: J Control Release. 2019 Aug 10;307:108-138. doi: 10.1016/j.jconrel.2019.06.017. Epub 2019 Jun 19. Impact factor: Publication type: Paper in international publication Authors: Arango, Diego; Carreira, Barbara; Conde, Joao P; Conniot, Joao; Florindo, Helena F; Fourniols, Thibaut; Martinez-Barriocanal, Agueda; Matos, Ana I; Moura, Liane I F; Peres, Carina et al. DOI: 10.1016/j.jconrel.2019.06.017 Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry. PMID: 31399146 Journal: Orphanet Journal of Rare Diseases Year: 2019 Reference: Orphanet J Rare Dis. 2019 Aug 9;14(1):196. doi: 10.1186/s13023-019-1172-8. Impact factor: 3.687 Publication type: Paper in international publication Authors: Gavin-Blanco, O, Riera-Mestre, Antoni, Mora-Lujan, Jose Maria, Trujillo-Santos, Javier, Del Toro, Jorge, Nieto, Jose Antonio, Pedrajas, Jose Maria, Lopez-Reyes, Raquel, Soler, Silvia, Ballaz, Aitor et al. DOI: 10.1186/s13023-019-1172-8 Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry. PMID: 31399146 Journal: Orphanet Journal of Rare Diseases Year: 2019 Reference: Orphanet J Rare Dis. 2019 Aug 9;14(1):196. doi: 10.1186/s13023-019-1172-8. Impact factor: Publication type: Paper in international publication Authors: Adarraga, M D; Agud, M; Aibar, M A; Alcalde-Manero, M; Alfonso, J; Amado, C; Arcelus, J I; Ballaz, A; Ballaz, Aitor; Barba, R et al. DOI: 10.1186/s13023-019-1172-8 NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial. PMID: 31296491 Journal: LANCET ONCOLOGY Year: 2019 Reference: Lancet Oncol. 2019 Aug;20(8):1148-1159. doi: 10.1016/S1470-2045(19)30326-2. Epub 2019 Jul 8. Impact factor: 35.386 Publication type: Paper in international publication Authors: Wardelmann, Eva, Mangel, Laszlo, Sy-Ortin, Teresa, Hohenberger, Peter, de Baere, Thierry, Le Cesne, Axel, Helfre, Sylvie, Saada-Bouzid, Esma, Borkowska, Aneta, Anghel, Rodica et al. DOI: 10.1016/S1470-2045(19)30326-2 NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial. PMID: 31296491 Journal: LANCET ONCOLOGY Year: 2019 Reference: Lancet Oncol. 2019 Aug;20(8):1148-1159. doi: 10.1016/S1470-2045(19)30326-2. Epub 2019 Jul 8. Impact factor: Publication type: Paper in international publication Authors: Agoston, Peter; Anghel, Rodica; Austen, Lyn; Bonvalot, Sylvie; Borkowska, Aneta; Bovee, Judith V M G; Carrere, Sebastien; Co, Ann; de Baere, Thierry; Dema, Sorin et al. DOI: 10.1016/S1470-2045(19)30326-2 Negative autoimmunity in a Spanish pediatric cohort suspected of type 1 diabetes, could it be monogenic diabetes? PMID: 31365591 Journal: PLoS One Year: 2019 Reference: PLoS One. 2019 Jul 31;14(7):e0220634. doi: 10.1371/journal.pone.0220634. eCollection 2019. Impact factor: 2.776 Publication type: Paper in international publication Authors: Urrutia, Ines, Martinez, Rosa, Rica, Itxaso, Martinez de LaPiscina, Idoia, Garcia-Castano, Alejandro, Aguayo, Anibal, Calvo, Begona, Castano, Luis, Campos Martorell, Ariadna, Clemente Leon, Maria et al. DOI: 10.1371/journal.pone.0220634 Negative autoimmunity in a Spanish pediatric cohort suspected of type 1 diabetes, could it be monogenic diabetes? PMID: 31365591 Journal: PLoS One Year: 2019 Reference: PLoS One. 2019 Jul 31;14(7):e0220634. doi: 10.1371/journal.pone.0220634. eCollection 2019. Impact factor: Publication type: Paper in international publication Authors: Aguayo, Anibal; Calvo, Begona; Campos Martorell, Ariadna; Castano, Luis; Clemente Leon, Maria; Garcia-Castano, Alejandro; Martinez de LaPiscina, Idoia; Martinez, Rosa; Rica, Itxaso; Spanish Pediat Diabet Collaborativ et al. DOI: 10.1371/journal.pone.0220634 Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. PMID: 31402321 Journal: LANCET ONCOLOGY Year: 2019 Reference: Lancet Oncol. 2019 Sep;20(9):1226-1238. doi: 10.1016/S1470-2045(19)30334-1. Epub 2019 Aug 8. Impact factor: 35.386 Publication type: Paper in international publication Authors: Saura, Cristina, Hlauschek, Dominik, Oliveira, Mafalda, Zardavas, Dimitrios, Jallitsch-Halper, Anita, de la Pena, Lorena, Nuciforo, Paolo, Ballestrero, Alberto, Dubsky, Peter, Lombard, Janine M et al. DOI: 10.1016/S1470-2045(19)30334-1 Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. PMID: 31402321 Journal: LANCET ONCOLOGY Year: 2019 Reference: Lancet Oncol. 2019 Sep;20(9):1226-1238. doi: 10.1016/S1470-2045(19)30334-1. Epub 2019 Aug 8. Impact factor: Publication type: Paper in international publication Authors: Ballestrero, Alberto; Bardia, Aditya; Baselga, Jose; Boer, Katalin; Castaneda, Carlos A; Ciruelos, Eva; Colleoni, Marco; de Azambuja, Evandro; de la Pena, Lorena; Dubsky, Peter et al. DOI: 10.1016/S1470-2045(19)30334-1 Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement. PMID: 30710068 Journal: ONCOLOGIST Year: 2019 Reference: Oncologist. 2019 May;24(5):603-611. doi: 10.1634/theoncologist.2018-0228. Epub 2019 Feb 1. Impact factor: 5.252 Publication type: Paper in international publication Authors: Colomer, Ramon, Saura, Cristina, Sanchez-Rovira, Pedro, Pascual, Tomas, Rubio, Isabel T, Burgues, Octavio, Marcos, Lourdes, Rodriguez, Cesar A, Martin, Miguel, Lluch, Ana et al. DOI: 10.1634/theoncologist.2018-0228 Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement. PMID: 30710068 Journal: ONCOLOGIST Year: 2019 Reference: Oncologist. 2019 May;24(5):603-611. doi: 10.1634/theoncologist.2018-0228. Epub 2019 Feb 1. Impact factor: Publication type: Paper in international publication Authors: Burgues, Octavio; Colomer, Ramon; Lluch, Ana; Marcos, Lourdes; Martin, Miguel; Pascual, Tomas; Rodriguez, Cesar A; Rubio, Isabel T; Sanchez-Rovira, Pedro; Saura, Cristina et al. DOI: 10.1634/theoncologist.2018-0228 Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer. PMID: 31835708 Journal: Journal of Clinical Medicine Year: 2019 Reference: J Clin Med. 2019 Dec 11;8(12). pii: jcm8122180. doi: 10.3390/jcm8122180. Impact factor: 5.688 Publication type: Paper in international publication Authors: Lopez-Bonet, Eugeni, Buxo, Maria, Cuyas, Elisabet, Pernas, Sonia, Dorca, Joan, Alvarez, Isabel, Martinez, Susana, Perez-Garcia, Jose Manuel, Batista-Lopez, Norberto, Rodriguez-Sanchez, Cesar A et al. DOI: 10.3390/jcm8122180 Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer. PMID: 31835708 Journal: Journal of Clinical Medicine Year: 2019 Reference: J Clin Med. 2019 Dec 11;8(12). pii: jcm8122180. doi: 10.3390/jcm8122180. Impact factor: Publication type: Paper in international publication Authors: Alvarez, Isabel; Amillano, Kepa; Batista-Lopez, Norberto; Brunet, Joan; Buxo, Maria; Castillo, Laura; Cortes, Javier; Cuyas, Elisabet; Dominguez, Severina; Dorca, Joan et al. DOI: 10.3390/jcm8122180 Pagination First page « First Previous page ‹ Previous … Page 747 Page 748 Page 749 Page 750 Current page 751 Page 752 Page 753 Page 754 Page 755 … Next page Next › Last page Last »
